Directory
>
Samuel Blackman
Samuel Blackman
Founder and Head of Research and Development | Presage Biosciences, Inc.
United States
Samuel Blackman
Summary
Samuel Blackman is a mission-driven physician-scientist and biotechnology executive with over 13 years of experience in oncology clinical development. He is the founder and Head of Research and Development at Day One Biopharmaceuticals, focusing on developing new therapeutics for pediatric cancer. Samuel has held significant roles at major pharmaceutical companies like Merck and GlaxoSmithKline, as well as at innovative startups. His expertise spans various facets of drug development, including small molecule therapies and immuno-oncology agents. He has authored multiple regulatory documents to support drug approvals in Europe. In addition to his scientific pursuits, Samuel is an accomplished storyteller, having performed at renowned storytelling events. His unique blend of clinical insight and creative expression sets him apart in the biopharmaceutical landscape.
Samuel Blackman
Work Experience
Founder and Head of Research and Development at
Day One Biopharmaceuticals
May 2023 - Present
Scientific Advisor at
Notable
January 2019 - Present
Board Member at
Presage Biosciences, Inc.
November 2018 - Present
Advisory Board Member at
Litmus Health
January 2016 - Present
Founder and Chief Medical Officer at
Day One Biopharmaceuticals
November 2018 - April 2023
Head of Clinical Development at
MAVUPHARMA, INC.
September 2018 - July 2019
Senior Vice President, Head of Clinical Development at
Silverback Therapeutics
August 2016 - September 2018
Senior Medical Director at
Juno Therapeutics, Inc.
June 2014 - August 2016
Executive Director, Head of Translational Medicine at
Seagen
July 2012 - May 2014
Director, Oncology Early Clinical Development at
GSK
August 2010 - July 2012
Associate Director - Experimental Medicine at
Merck
March 2008 - August 2010
Staff Physician at
Children's Hospital of Philadelphia
December 2008 - June 2010
Physician Consultant at
Consumers Medical Resource
May 2007 - November 2009
Attending Physician in Pediatric Oncology at
Dana-Farber Cancer Institute
January 2008 - March 2008
Fellow in Pediatric Oncology at
Boston Children's Hospital
January 2004 - January 2006
Resident/Fellow Representative - Council on Scientific Affairs at
American Medical Association
January 2003 - January 2006
Resident in Pediatrics at
Cincinnati Children's
July 2001 - June 2004
MD/PhD Student at
University Of Illinois At Chicago College Of Medicine
August 1993 - June 2001
Research Assistant at
University Of Chicago
January 1990 - January 1993
Samuel Blackman
Education
University of Illinois College of Medicine, Md
January 1993 - January 2001
University of Illinois Chicago, Phd
January 1993 - January 2001
University of Chicago, Ba
January 1986 - January 1990
Frequently Asked Questions about Samuel Blackman
What is Samuel Blackman email address?
Samuel Blackman's primary email address is *********@notablelabs.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Samuel Blackman work for?
Samuel Blackman is a Founder and Head of Research and Development at Presage Biosciences, Inc., a company specializing in Commercial physical research.
Where Samuel Blackman graduated from?
Samuel Blackman holds a degree in Medicine from University of Illinois College of Medicine.
How can I directly contact Samuel Blackman?
To contact Samuel Blackman directly, you can use the email address *********@notablelabs.com. Complete contact information is available upon registration with Muraena.
Who is Samuel Blackman?
Samuel Blackman is a mission-driven physician-scientist and biotechnology executive with over 13 years of experience in oncology clinical development. He is the founder and Head of Research and Development at Day One Biopharmaceuticals, focusing on developing new therapeutics for pediatric cancer. Samuel has held significant roles at major pharmaceutical companies like Merck and GlaxoSmithKline, as well as at innovative startups. His expertise spans various facets of drug development, including small molecule therapies and immuno-oncology agents. He has authored multiple regulatory documents to support drug approvals in Europe. In addition to his scientific pursuits, Samuel is an accomplished storyteller, having performed at renowned storytelling events. His unique blend of clinical insight and creative expression sets him apart in the biopharmaceutical landscape.
Samuel`s contact details
*********@notablelabs.com
******@litmushealth.com
***************@dayonebio.com
***************@presagebio.com